Akebia Therapeutics Stock Forecast
About Chart
Golden Star
The Golden Star is a refined bullish signal based on the Golden Cross, developed by Jim Stromberg, incorporating additional time frame-specific moving averages and precise price line crossings. This signal is effective for liquid stocks, highlighting short-term upward momentum.
Death Star
The Death Star, developed by Jim Stromberg, is the bearish counterpart to the Golden Star, serving as a sell signal. It is triggered by specific moving average crossings on the price line, indicating a likely prolonged decline in the stock.
Golden Cross
The Golden Cross is a bullish signal where the short-term moving average crosses above the long-term moving average, indicating potential upward momentum.
Death Cross
The Death Cross is a bearish signal where the short-term moving average crosses below the long-term moving average, indicating potential downward momentum.
Pivot Bottom
A Pivot Bottom is a significant low point identified by algorithms developed by StockInvest.us. While it may indicate a short-term directional change, it does not necessarily imply a complete trend reversal. Pivot Bottoms are marked as green circles on the price line.
Pivot Top
A Pivot Top represents a significant high point identified by algorithms developed by StockInvest.us. Similar to Pivot Bottoms, it may suggest a short-term directional change within the main trend, rather than a full trend reversal. Pivot Tops are marked as red circles on the price line.
RSI Oversold
RSI oversold indicates that a stock has declined significantly and may be undervalued, potentially presenting a buying opportunity. This condition is marked by a green line on the chart but should be confirmed with other indicators before taking action.
RSI Overbought
RSI overbought suggests that a stock has risen rapidly and may be due for a pullback. It is marked by a red line on the chart, signaling increased risk. This doesn’t necessarily mean it’s time to sell, but it’s important to monitor closely.
Accumulated Volume
The bars indicate how much stock has been traded on each price during the chart period.
Buy Signal (MA)
Buy Signal from Moving Average: Indicates potential upward movement.
Sell Signal (MA)
Sell Signal from Moving Average: Indicates potential downward movement.
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
AI Analysis of AKBA
| Stock Analysis |
|
| Risk Assessment |
|
| Trading Strategy |
|
Akebia Therapeutics stock price up 0.758% on Friday
(Updated on Oct 04, 2024)
Sell candidate since Sep 17, 2024
Loss -2.92%
The Akebia Therapeutics stock price gained 0.758% on the last trading day (Friday, 4th Oct 2024), rising from $1.32 to $1.33. During the last trading day the stock fluctuated 3.05% from a day low at $1.31 to a day high of $1.35. The price has fallen in 5 of the last 10 days and is down by -2.92% for this period. Volume fell on the last day by -150 thousand shares and in total, 793 thousand shares were bought and sold for approximately $1.05 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 10.92% during the next 3 months and, with a 90% probability hold a price between $1.21 and $1.79 at the end of this 3-month period.
AKBA Signals & Forecast
There are mixed signals in the stock today. The Akebia Therapeutics stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.41. On a fall, the stock will find some support from the short-term average at $1.32. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Friday, August 30, 2024, and so far it has fallen -14.19%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Akebia Therapeutics stock
Akebia Therapeutics finds support from accumulated volume at $1.31 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0400 between high and low, or 3.05%. For the last week the stock has had daily average volatility of 4.69%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (AKBA) For The Upcoming Trading Day Of Monday 7th
For the upcoming trading day on Monday, 7th we expect Akebia Therapeutics to open at $1.33, and during the day (based on 14 day Average True Range), to move between $1.26 and $1.40, which gives a possible trading interval of +/-$0.0685 (+/-5.15%) up or down from last closing price. If Akebia Therapeutics takes out the full calculated possible swing range there will be an estimated 10.30% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $1.35 (1.50%) than the support at $1.31 (1.50%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Akebia Therapeutics stock A Buy?
Akebia Therapeutics holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score:
-3.340
Sell Candidate
Unchanged
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
Predicted Fair Opening Price
Predicted fair opening price on October 7, 2024 - $1.33 ( 0%). The predicted opening price is based on yesterday's movements between high, low, and closing price.Trading levels for AKBA
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 1.37 | 3.01% |
| R2 | 1.35 | 1.86% |
| R1 | 1.35 | 1.15% |
| Price | 1.33 | |
| S1 | 1.31 | -1.15% |
| S2 | 1.31 | -1.86% |
| S3 | 1.29 | -3.01% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 1.44 | 8.27% |
| R2 | 1.37 | 3.01% |
| R1 | 1.35 | 1.50% |
| Price | 1.33 | |
| S1 | 1.31 | -1.50% |
| S2 | 1.27 | -4.51% |
| S3 | 1.26 | -5.26% |
FAQ
Click here for our free guide on how to buy Akebia Therapeutics Stock.
